News
News

News

01/12/2021 STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics

STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics

Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million  Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarter HORSHAM, Pa. , Jan.
01/12/2021 STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”

STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”

HORSHAM, Pa. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the
01/06/2021 STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference

STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference

HORSHAM, Pa. , Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic